C-reactive protein and cardiovascular disease in peritoneal dialysis patients
Open Access
- 1 October 2002
- journal article
- Published by Elsevier in Kidney International
- Vol. 62 (4) , 1417-1422
- https://doi.org/10.1046/j.1523-1755.2002.00562.x
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patientsKidney International, 2001
- Procalcitonin: a new marker of inflammation in haemodialysis patients?Nephrology Dialysis Transplantation, 2001
- End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?Kidney International, 2001
- Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patientsKidney International, 2000
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999
- C-reactive protein as an outcome predictor for maintenance hemodialysis patientsKidney International, 1998
- Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control studyAtherosclerosis, 1996
- Induction of tumour necrosis factor-alpha during haemodialysis. Influence of the membrane typeClinical and Experimental Immunology, 1991
- Elevated Serum Levels of C-Reactive Protein in Hemodialysis PatientsNephron, 1990
- Human Interleukin-1 Production during HemodialysisNephron, 1986